Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 1409

    1.

    Neoadjuvant chemoradiation followed by surgery versus surgery alone for patients with adenocarcinoma or squamous cell carcinoma of the esophagus (CROSS).

    van Heijl M, van Lanschot JJ, Koppert LB, van Berge Henegouwen MI, Muller K, Steyerberg EW, van Dekken H, Wijnhoven BP, Tilanus HW, Richel DJ, Busch OR, Bartelsman JF, Koning CC, Offerhaus GJ, van der Gaast A.

    BMC Surg. 2008 Nov 26;8:21.PMID: 19036143 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Preoperative therapy with concurrent paclitaxel/carboplatin/infusional 5-FU and radiation therapy in locoregional esophageal cancer: final results of a Minnie Pearl Cancer Research Network phase II trial.

    Meluch AA, Greco FA, Gray JR, Thomas M, Sutton VM, Davis JL, Kalman LA, Shaffer DW, Yost K, Rinaldi DA, Hainsworth JD.

    Cancer J. 2003 Jul-Aug;9(4):251-60.PMID: 12967135 [PubMed - indexed for MEDLINE]Related articles

    3.

    Mature survival results with preoperative cisplatin, protracted infusion 5-fluorouracil, and 44-Gy radiotherapy for esophageal cancer.

    Kleinberg L, Knisely JP, Heitmiller R, Zahurak M, Salem R, Burtness B, Heath EI, Forastiere AA.

    Int J Radiat Oncol Biol Phys. 2003 Jun 1;56(2):328-34.PMID: 12738305 [PubMed - indexed for MEDLINE]Related articles

    4.

    A three-step strategy of induction chemotherapy then chemoradiation followed by surgery in patients with potentially resectable carcinoma of the esophagus or gastroesophageal junction.

    Ajani JA, Komaki R, Putnam JB, Walsh G, Nesbitt J, Pisters PW, Lynch PM, Vaporciyan A, Smythe R, Lahoti S, Raijman I, Swisher S, Martin FD, Roth JA.

    Cancer. 2001 Jul 15;92(2):279-86.PMID: 11466680 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    A comparative longitudinal quality of life study using the Spitzer quality of life index in a randomized multicenter phase III trial (FFCD 9102): chemoradiation followed by surgery compared with chemoradiation alone in locally advanced squamous resectable thoracic esophageal cancer.

    Bonnetain F, Bouché O, Michel P, Mariette C, Conroy T, Pezet D, Roullet B, Seitz JF, Paillot B, Arveux P, Milan C, Bedenne L.

    Ann Oncol. 2006 May;17(5):827-34. Epub 2006 Mar 8.PMID: 16524973 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    Esophagectomy after concurrent chemoradiotherapy improves locoregional control in clinical stage II or III esophageal cancer patients.

    Liao Z, Zhang Z, Jin J, Ajani JA, Swisher SG, Stevens CW, Ho L, Smythe R, Vaporciyan AA, Putnam JB Jr, Walsh GL, Roth JA, Yao JC, Allen PK, Cox JD, Komaki R.

    Int J Radiat Oncol Biol Phys. 2004 Dec 1;60(5):1484-93.PMID: 15590179 [PubMed - indexed for MEDLINE]Related articles

    8.

    A highly active and tolerable neoadjuvant regimen combining paclitaxel, carboplatin, 5-FU, and radiation therapy in patients with stage II and III esophageal cancer.

    van de Schoot L, Romme EA, van der Sangen MJ, Creemers GJ, van Lijnschoten G, van Driel OJ, Rutten HJ, Nieuwenhuijzen GA.

    Ann Surg Oncol. 2008 Jan;15(1):88-95. Epub 2007 Sep 26.PMID: 17896144 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    Phase II evaluation of preoperative chemoradiation and postoperative adjuvant chemotherapy for squamous cell and adenocarcinoma of the esophagus.

    Heath EI, Burtness BA, Heitmiller RF, Salem R, Kleinberg L, Knisely JP, Yang SC, Talamini MA, Kaufman HS, Canto MI, Topazian M, Wu TT, Olukayode K, Forastiere AA.

    J Clin Oncol. 2000 Feb;18(4):868-76.PMID: 10673530 [PubMed - indexed for MEDLINE]Related articles

    10.

    Neoadjuvant concurrent chemoradiation with weekly paclitaxel and carboplatin for patients with oesophageal cancer: a phase II study.

    van Meerten E, Muller K, Tilanus HW, Siersema PD, Eijkenboom WM, van Dekken H, Tran TC, van der Gaast A.

    Br J Cancer. 2006 May 22;94(10):1389-94.PMID: 16670722 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    Neoadjuvant concurrent chemoradiotherapy followed by definitive high-dose radiotherapy or surgery for operable thoracic esophageal carcinoma.

    Murakami M, Kuroda Y, Okamoto Y, Kono K, Yoden E, Kusumi F, Hajiro K, Matsusue S, Takeda H.

    Int J Radiat Oncol Biol Phys. 1998 Mar 15;40(5):1049-59.PMID: 9539559 [PubMed - indexed for MEDLINE]Related articles

    12.

    Twice-daily radiotherapy as concurrent boost technique during two chemotherapy cycles in neoadjuvant chemoradiotherapy for resectable esophageal carcinoma: mature results of phase II study.

    Choi N, Park SD, Lynch T, Wright C, Ancukiewicz M, Wain J, Donahue D, Mathisen D.

    Int J Radiat Oncol Biol Phys. 2004 Sep 1;60(1):111-22.PMID: 15337546 [PubMed - indexed for MEDLINE]Related articles

    13.

    Induction chemotherapy improved outcomes of patients with resectable esophageal cancer who received chemoradiotherapy followed by surgery.

    Jin J, Liao Z, Zhang Z, Ajani J, Swisher S, Chang JY, Jeter M, Guerrero T, Stevens CW, Vaporciyan A, Putnam J Jr, Walsh G, Smythe R, Roth J, Yao J, Allen P, Cox JD, Komaki R.

    Int J Radiat Oncol Biol Phys. 2004 Oct 1;60(2):427-36.PMID: 15380576 [PubMed - indexed for MEDLINE]Related articles

    14.

    Influence of hemoglobin levels on survival after radical treatment of esophageal carcinoma with radiotherapy.

    Valencia Julve J, Alonso Orduña V, Escó Barón R, López-Mata M, Méndez Villamón A.

    Clin Transl Oncol. 2006 Jan;8(1):22-30.PMID: 16632436 [PubMed - indexed for MEDLINE]Related articles

    15.

    Neoadjuvant chemoradiation therapy in patients with surgically treated esophageal cancer.

    Vermund H, Pories WJ, Hillard J, Wiley AL, Youngblood R.

    Acta Oncol. 2001;40(5):558-65. Review.PMID: 11669326 [PubMed - indexed for MEDLINE]Related articles

    16.

    Patterns of failure following combined modality therapy for esophageal cancer, 1984-1990.

    Kavanagh B, Anscher M, Leopold K, Deutsch M, Gaydica E, Dodge R, Allen K, Allen D, Staub W, Montana G, et al.

    Int J Radiat Oncol Biol Phys. 1992;24(4):633-42.PMID: 1429085 [PubMed - indexed for MEDLINE]Related articles

    17.

    A single institutional phase III trial of preoperative chemotherapy with hyperfractionation radiotherapy plus surgery versus surgery alone for resectable esophageal squamous cell carcinoma.

    Lee JL, Park SI, Kim SB, Jung HY, Lee GH, Kim JH, Song HY, Cho KJ, Kim WK, Lee JS, Kim SH, Min YI.

    Ann Oncol. 2004 Jun;15(6):947-54.PMID: 15151953 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    Survival following intensive preoperative combined modality therapy with paclitaxel, cisplatin, 5-fluorouracil, and radiation in resectable esophageal carcinoma: a phase I report.

    Goldberg M, Farma J, Lampert C, Colarusso P, Coia L, Frucht H, Goosenberg E, Beard M, Weiner LM.

    J Thorac Cardiovasc Surg. 2003 Oct;126(4):1168-73.PMID: 14566264 [PubMed - indexed for MEDLINE]Related articles

    19.

    [Chemoradiotherapy followed by surgery in treatment of locally advanced esophageal carcinoma: a phase II trial]

    Fu JH, Rong TH, Li XD, Hu Y, Ou W, Hu YH, Li Q.

    Ai Zheng. 2004 Nov;23(11 Suppl):1473-6. Chinese. PMID: 15566661 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    Induction chemotherapy followed by concomitant TFHX chemoradiotherapy with reduced dose radiation in advanced head and neck cancer.

    Haraf DJ, Rosen FR, Stenson K, Argiris A, Mittal BB, Witt ME, Brockstein BE, List MA, Portugal L, Pelzer H, Weichselbaum RR, Vokes EE.

    Clin Cancer Res. 2003 Dec 1;9(16 Pt 1):5936-43.PMID: 14676118 [PubMed - indexed for MEDLINE]Related articlesFree article

    Display Settings:

    Format
    Items per page
    Sort by

    Send to:

    Choose Destination

    Supplemental Content

    Find related data